Leptomeningeal Disease in HER2-Positive Metastatic Breast Cancer

Leptomeningeal disease, involving metastases in cerebrospinal fluid and membranes around the brain and spinal cord, affects approximately 110,000 new cases annually in the U.S. The condition is noted in HER2-positive metastatic breast cancer patients, with incidence varying among different cancers.